A Randomized-Controlled Trial of Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
Phase: PHASE2 | Sponsor: Icahn School of Medicine at Mount Sinai | Compound: Ketamine
- Status
- recruiting
- Institution
- Icahn School of Medicine at Mount Sinai
- Start date
- 2025-01-10
- End date
- 2027-08-01
- Registry ID
- NCT06559826
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.